Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The prediction had a final performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | -3.689% | -3.689% | 47.045% | 9.675% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% | 49.597% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% | 80.868% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% | 60.373% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% | 60.000% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Buy mit Kursziel 22,0
In the thread Trading Acadia Pharmaceuticals
Buy beendet

